# Bristol Myers Squibb will offer Eliquis, its blockbuster blood thinner and top-prescribed product, for free to Medicaid.

*biotech · news · 2025-12-19 · CNBC*

## Key points

- Nine major drugmakers agreed to lower U.S. drug prices in exchange for tariff exemptions and investment pledges.
- Bristol Myers Squibb will provide its top-selling blood thinner Eliquis for free to Medicaid patients.
- The companies must sell drugs to Medicaid at lowest 'most favored nation' prices and guarantee that for new medicines.
- Merck and Sanofi will offer up to 70% discounts on selected drugs via direct-to-consumer programs like TrumpRx.
- Full deal terms remain undisclosed, making the actual scope and impact of these agreements uncertain.

**Companies:** Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche, Genentech, Novartis, Boehringer Ingelheim
**Countries:** United States, Europe

[Read the full story on CNBC](https://www.cnbc.com/2025/12/19/nine-pharma-companies-ink-deals-with-trump-to-lower-drug-prices.html)

---

Canonical: https://newsio.io/n/55f5f0cc-8df5-4b0f-b4f8-65468f1ae1ec/bristol-myers-squibb-will-offer-eliquis-its-blockbuster-blood-thinner-and-top-pr
Summarized by Newsio from CNBC. https://newsio.io/how-it-works